Aurobindo, Hetero, and Vivimed Class Action Settlements in Illinois
Aurobindo, Hetero, and Vivimed class action settlements that covered Illinois residents — and where each one now stands.
Last checked: August 11, 2026 · By Class Action Buddy
Illinois residents have no confirmed open class action settlements involving Aurobindo, Hetero, and Vivimed right now. The Aurobindo, Hetero, and Vivimed settlement below has closed — the claim deadline has passed and no new claims can be filed. If you are looking for something you can still claim, our list of open settlements is checked against each administrator.
Class Action Buddy fills in official claim forms from your saved profile in under 60 seconds, then prints and posts the completed claim for you. There is nothing to file against Aurobindo, Hetero, and Vivimed at the moment — see what is open now.
Closed Aurobindo, Hetero, and Vivimed Settlements for Illinois Residents (1)
This Aurobindo, Hetero, and Vivimed settlement is no longer accepting claims. It closed on the date shown and the deadline cannot be reopened. It is listed here because the settlement and its administrator are a matter of record and people still search for it. For settlements that are open today, see our list of open settlements.
$15.2M Valsartan, Losartan and Irbesartan class action settlement
Up to TBDFile your claim for the $15.2M Valsartan, Losartan, and Irbesartan settlement. Blood pressure medication contaminated with cancer-causing substances.
About Aurobindo, Hetero, and Vivimed Class Actions in Illinois
Before you read on: the Aurobindo, Hetero, and Vivimed settlement described below has closed. This section explains what it was about and who was covered, which is still worth knowing — but it cannot be claimed now. See settlements that are open today.
Illinois residents affected by contaminated blood pressure medications from Aurobindo, Hetero, and Vivimed face significant legal options under state consumer protection laws. The Illinois Consumer Fraud and Deceptive Business Practices Act provides stronger protections than federal regulations, allowing residents to pursue damages for deceptive practices in pharmaceutical manufacturing. These three Indian pharmaceutical companies supply generic medications extensively throughout Illinois, with distribution networks serving major hospital systems and pharmacy chains across Chicago, Rockford, and Peoria metropolitan areas. Illinois residents filing class action claims must be aware that the state follows a modified comparative negligence standard, meaning compensation may be reduced if plaintiffs bear partial responsibility for damages. The Illinois Attorney General's office has actively pursued pharmaceutical companies for consumer protection violations, creating precedent for successful settlements. Given Illinois' two-year statute of limitations for personal injury claims and five-year limit for consumer fraud cases, residents should act promptly when joining class action settlements involving contaminated medications from these manufacturers.
Aurobindo, Hetero, and Vivimed Settlements in Illinois: FAQs
What makes Illinois law particularly favorable for Aurobindo, Hetero, and Vivimed settlement claims?
Illinois Consumer Fraud and Deceptive Business Practices Act allows treble damages and attorney fees for successful pharmaceutical fraud cases. The state's consumer protection laws are broader than federal regulations, covering deceptive manufacturing practices that resulted in NDMA-contaminated blood pressure medications.
How does the $15.2M Valsartan settlement specifically benefit Illinois residents who used Aurobindo, Hetero, or Vivimed medications?
Illinois residents who purchased contaminated Valsartan, Losartan, or Irbesartan from these manufacturers between 2012-2018 can claim compensation without proving physical injury. The settlement covers out-of-pocket costs, medical monitoring, and punitive damages under Illinois consumer protection statutes.
What documentation do Illinois residents need to file claims against Aurobindo, Hetero, and Vivimed?
Illinois claimants need prescription records, pharmacy receipts, and proof of Illinois residency during the contamination period. The Illinois Department of Financial and Professional Regulation maintains pharmacy dispensing records that can help verify purchases of affected generic medications from these three manufacturers.
Tips for Illinois Residents Filing Aurobindo, Hetero, and Vivimed Claims
Illinois residents filing Aurobindo, Hetero, and Vivimed claims should gather all prescription bottles, pharmacy receipts, and medical records from 2012-2018 when NDMA contamination occurred. Contact your pharmacy for detailed dispensing records showing manufacturer names, as generic medications often don't display the actual producer. File claims promptly within Illinois' statute of limitations periods. Consider consulting Illinois-licensed attorneys familiar with pharmaceutical class actions, as the state's consumer protection laws may provide additional damages beyond federal settlements. Keep copies of all documentation and correspondence related to your claim filing process.
File Aurobindo, Hetero, and Vivimed Claims in 60 Seconds
Class Action Buddy auto-fills your claim forms and submits them electronically. Your first claim is free.
